research

Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma

Authors
Publication date
1 January 2014
Publisher
Springer Nature
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Springer - Publisher Connector

      redirect
      Last time updated on 28/04/2017